ReviewHuman vaccines & immunotherapeutics2014
Oral immunotherapy for the treatment of food allergy.
Review in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial.Scientific reports · 2017Trial
- Gut commensal bacteria-derived polysaccharide sub-micron particles induce antigen-specific, tolerogenic responses.Frontiers in immunology · 2025Article
- Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy.Medicina (Kaunas, Lithuania) · 2024Review
- Article
- Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022Article
- Peanut allergy: Beyond the oral immunotherapy plateau.Clinical and translational allergy · 2021Review
- Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes.The journal of allergy and clinical immunology. In practice · 2021Review
- Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond.Frontiers in allergy · 2021Article
- Recent advances in mechanisms of food allergy and anaphylaxis.F1000Research · 2020Review
- Cashew Nut Allergy: Clinical Relevance and Allergen Characterisation.Clinical reviews in allergy & immunology · 2019Review
- Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases.F1000Research · 2018Review
- Immunotherapy for cow's milk allergy.Human vaccines & immunotherapeutics · 2017Review
- Update on oral immunotherapy for egg allergy.Human vaccines & immunotherapeutics · 2017Review
- Article
- Molecular and cellular mechanisms of food allergy and food tolerance.The Journal of allergy and clinical immunology · 2016Review
- The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions.Current allergy and asthma reports · 2016Review
- Immune mechanisms of sublingual immunotherapy.Current allergy and asthma reports · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral immunotherapy (OIT) is an emerging new therapy for food allergy. With multiple small exploratory trials and some large randomized-controlled phase 2 trials recently published and under way, there is a clear progress and interest toward making this a treatment option for patients suffering from food allergies. However, there are still many questions to be answered and parameters to fine-tune before OIT becomes an accepted option outside of the research setting. This review covers the main milestones in the development of OIT for food allergy and further discusses important specific issues that will have direct impact on its clinical application. More specifically, previous publications showing evidence for the induction of tolerance are specifically reviewed and varying safety, tolerability and efficacy parameters from previous reports are also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.